CompletedNot Applicable

Prediction of Preterm Delivery by Serum Ischemia Modified Albumin, Biglycan and Decorin Levels in Women With Threatened Preterm Labour

Turkey (Türkiye)51 participantsStarted 2019-12-01

Plain-language summary

In this study, the levels of ischemia modified albumin, biglycan and decorin in the serums of pregnant women hospitalized for preterm labor will be examined. Their serum levels will be compared between women having preterm and term delivery. Their accuracy will be asessed in predicting preterm birth.

Who can participate

Age range18 Years – 42 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Singleton pregnancy * Gestational age is between 24-37 weeks * Cervical dilatation less than 3 cm and cervical effacement less than 80% * Uterine contraction ≥3 times at 30 minutes * Intact amniotic membrane Exclusion Criteria: * Multiple pregnancy * Preterm premature rupture of membranes * Abnormal placentation (such as placenta previa) * Uterine anomaly * Maternal heart disease * Inflammatory or infectious disease * Preeclampsia * Fetal growth restriction * Congenital fetal anomaly * Polyhydramnios * Acute chorioamnionitis * Medically induced preterm delivery

What they're measuring

Gestational age at birth

Timeframe: December 2019 - January 2021

Trial details

NCT IDNCT04451928

SponsorIsmail Biyik

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2021-02-05

View on ClinicalTrials.gov More Preterm Birth trials